Apis Capital Advisors, LLC Aerie Pharmaceuticals Inc Transaction History

Apis Capital Advisors, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$18.41 - $28.0 $368,200 - $560,000	-20,000 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$28.97 - $48.21 $289,700 - $482,100	-10,000 Reduced 33.33%	20,000 $591,000
Q1 2019 May 07, 2019	BUY	$36.32 - $49.25 $1.09 Million - $1.48 Million	30,000 New	30,000 $1.43 Million

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Apis Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Apis Capital Advisors, LLC with notifications on news.